ARCHIVES

NCI to Establish Three Grants Programs Supporting Clinical Cancer Research

This article is from The Cancer Letter archive.

Vol. 20 No. 07 | February 18, 1994

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

ASCO Updates Guideline On Follow-Up Management

October 27, 2006

Polymer Platinate Begins Testing In Phase I Trial.

September 29, 2000

DCPC Board Commits More Than $100 Million To 15-Year Trial Of Low Fat Diet In Women

October 26, 1990

NCAB Votes to Bring Organ Systems Coordinating Center Into NCI, Disperse Entire Grants Portfolio

February 12, 1988

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013